Original articlesOnco-ImmunologyClinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
Onco-Immunology
Under an Elsevier user license
open archive
Keywords
triple-negative breast cancer
CD73
immunotherapy
Cited by (0)
Copyright © 2017 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.